Literature DB >> 7061356

Severe staphylococcal infections treated with vancomycin.

M T Cafferkey, R Hone, C T Keane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061356     DOI: 10.1093/jac/9.1.69

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  9 in total

Review 1.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

2.  Determination of vancomycin in human serum by high-pressure liquid chromatography.

Authors:  F Jehl; C Gallion; R C Thierry; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

3.  Vancomycin Serum Concentration Monitoring : The Middle Ground is Best.

Authors:  F Marra; B Cairns; P Jewesson
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

Review 4.  Diagnosis and management of methicillin resistant Staphylococcus aureus infection.

Authors:  G J Duckworth
Journal:  BMJ       Date:  1993-10-23

Review 5.  Severe infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  C T Keane; M T Cafferkey
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

Review 6.  Vancomycin ototoxicity and nephrotoxicity. A review.

Authors:  G R Bailie; D Neal
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 7.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

8.  In vitro activity of combinations of antibiotics against Staphylococcus aureus resistant to gentamicin and methicillin.

Authors:  S Dixson; W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1985 Jan-Feb       Impact factor: 3.553

9.  In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.

Authors:  P E Varaldo; E Debbia; G C Schito
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.